UNSPSC 85503741: Dilation of upper artery with drug-eluting intraluminal device, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to dilation of upper artery with drug-eluting intraluminal device, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 037Y34Z

UNSPSC 85503741 Dilation of upper artery with drug-eluting intraluminal device, percutaneous approach is a Commodity code that does not align with the recent state and local opportunities posted under it. The code nominally describes a specific surgical procedure involving vascular intervention with specialized medical devices; however, the six recent opportunities tagged to this code span independent medical evaluations for public safety pension boards, surgical benefit carve-out programs for municipal employees, occupational health surveillance for state ferry workers, emergency and specialty medical services for detained youth, pharmacy benefit management administration, and temporary health professional staffing. None of these solicitations involve the procurement of drug-eluting vascular devices or related procedural services. The mismatch suggests either a data-entry error in the state and local procurement systems or that the code has been repurposed in practice to encompass broader healthcare services contracting rather than the specific interventional cardiology or vascular procedure it nominally describes.

The issuing bodies include municipal retirement offices (City of Phoenix), city employee health benefit programs (City of Long Beach), state transportation agencies (Washington State Department of Transportation), county juvenile justice systems (Harris County), county health coalitions (Collier County), and regional health systems (County of Santa Clara). Geographic activity spans Arizona, California, Washington, Texas, and Florida, with no clear concentration. Given the disconnect between the code's nominal scope and the actual work being solicited, procurement professionals should treat this code as unreliable for targeting medical device or interventional vascular service opportunities and should instead track relevant opportunities through direct agency monitoring or alternative UNSPSC classifications aligned with healthcare administration, staffing, or benefit management services.